chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Adverse event, Blood test, Platelet count, Platelet count increased
Clinical narrative: same side effects; Platelets were up; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (same side effects) and PLATELET COUNT INCREASED (Platelets were up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced ADVERSE EVENT (same side effects) and PLATELET COUNT INCREASED (Platelets were up). At the time of the report, ADVERSE EVENT (same side effects) and PLATELET COUNT INCREASED (Platelets were up) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood test: normal (normal) blood work was unusually good. In 2021, Platelet count: high (High) platelets were up.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     .   This case was linked to MOD-2021-054300 (Patient Link).   Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Pain in extremity
Clinical narrative: Diarrhea; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B2114) for COVID-19 vaccination.     Concurrent medical conditions included Lupoid dermatitis and Fibromyalgia. Concomitant products included PREGABALIN (LYRICA), BACLOFEN and AZATHIOPRINE (AZOPINE) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm). At the time of the report, DIARRHOEA (Diarrhea) and PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications Lyrica, baclofen, azopine  topical gel Treatment details included drinking lots of water to keep hydrated her self Action taken with mRNA-1273 in response to the event was unknown   This case was linked to MOD-2021-089573 (Patient Link).
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Felt liquid dripping down her arm without any feeling of a needlestick; Felt liquid dripping down her arm without any feeling of a needlestick; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (Felt liquid dripping down her arm without any feeling of a needlestick) and UNDERDOSE (Felt liquid dripping down her arm without any feeling of a needlestick) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced DEVICE CONNECTION ISSUE (Felt liquid dripping down her arm without any feeling of a needlestick) and UNDERDOSE (Felt liquid dripping down her arm without any feeling of a needlestick). On 23-Mar-2021, DEVICE CONNECTION ISSUE (Felt liquid dripping down her arm without any feeling of a needlestick) and UNDERDOSE (Felt liquid dripping down her arm without any feeling of a needlestick) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.  No treatment medication provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: No new information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: trouble scheduling a second dose/she waited too long already and today 22Mar2021 would put her at day 49; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (trouble scheduling a second dose/she waited too long already and today 22Mar2021 would put her at day 49) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012MA20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (trouble scheduling a second dose/she waited too long already and today 22Mar2021 would put her at day 49). At the time of the report, PRODUCT DOSE OMISSION ISSUE (trouble scheduling a second dose/she waited too long already and today 22Mar2021 would put her at day 49) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.  No concomitant medication was provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: High fever of 102°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (High fever of 102°F) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 01-Dec-2020.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (High fever of 102°F). At the time of the report, PYREXIA (High fever of 102°F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, Pyrexia: (High) 102°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Periorbital oedema
Clinical narrative: Swelling around right eye Looks like "got stung by a bee"; This spontaneous case was reported by a consumer and describes the occurrence of PERIORBITAL OEDEMA (Swelling around right eye Looks like "got stung by a bee") in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (dermatological fillers around both her eyes and lips.). Concomitant products included DROSPIRENONE, ETHINYLESTRADIOL BETADEX CLATHRATE (YAZ), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and LISDEXAMFETAMINE MESILATE (VYVANSE) for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PERIORBITAL OEDEMA (Swelling around right eye Looks like "got stung by a bee"). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Adverse event, at a dose of 180 milligram. At the time of the report, PERIORBITAL OEDEMA (Swelling around right eye Looks like "got stung by a bee") had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03K20A?) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain). At the time of the report, PAIN IN EXTREMITY (arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Warmth at the injection site; Little bit swelling at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE SWELLING (Little bit swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE SWELLING (Little bit swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE WARMTH (Warmth at the injection site), VACCINATION SITE SWELLING (Little bit swelling at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 23-Aug-2020 and the estimated date of delivery was 11-May-2021. On 18-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-ninth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 18-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was given.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site pain, Vaccination site warmth
Clinical narrative: AREA AROUND THE INJECTION SITE IS WARM TO TOUCH; ITCHING IN ARM; red remark; injection which is hot to the touch and it hurts; AREA AROUND INJECTION SITE IS RED; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED). At the time of the report, VACCINATION SITE WARMTH (AREA AROUND THE INJECTION SITE IS WARM TO TOUCH), PRURITUS (ITCHING IN ARM), VACCINATION SITE ERYTHEMA (red remark), VACCINATION SITE PAIN (injection which is hot to the touch and it hurts) and VACCINATION SITE ERYTHEMA (AREA AROUND INJECTION SITE IS RED) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant products were not provided. Treatment medication were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Reporter's details, Patient's age, Patient route of administration, Vaccination site warmth, Vaccination site erythema and Pruritus events were added.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Fatigue, Feeling abnormal, Headache
Clinical narrative: very sick, day 4 stayed in bed, felt awful.; felt awful; back pain; all her body, in elbow both arm especially and back pain; headaches; super significant joint pain, very painful; fatigue, tiredness; pain and tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and HEADACHE (headaches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04SA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain and tenderness at the injection site). On 19-Mar-2021, the patient experienced BACK PAIN (back pain), PAIN (all her body, in elbow both arm especially and back pain), HEADACHE (headaches), ARTHRALGIA (super significant joint pain, very painful) and FATIGUE (fatigue, tiredness). On 22-Mar-2021, the patient experienced FEELING ABNORMAL (felt awful) and ILLNESS (very sick, day 4 stayed in bed, felt awful.). On 22-Mar-2021, HEADACHE (headaches) and ARTHRALGIA (super significant joint pain, very painful) had resolved. At the time of the report, FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and VACCINATION SITE PAIN (pain and tenderness at the injection site) outcome was unknown and FATIGUE (fatigue, tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Pain, Vaccination site pain
Clinical narrative: very sick, day 4 stayed in bed, felt awful.; felt awful; back pain; all her body, in elbow both arm especially and back pain; headaches; super significant joint pain, very painful; fatigue, tiredness; pain and tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and HEADACHE (headaches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04SA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain and tenderness at the injection site). On 19-Mar-2021, the patient experienced BACK PAIN (back pain), PAIN (all her body, in elbow both arm especially and back pain), HEADACHE (headaches), ARTHRALGIA (super significant joint pain, very painful) and FATIGUE (fatigue, tiredness). On 22-Mar-2021, the patient experienced FEELING ABNORMAL (felt awful) and ILLNESS (very sick, day 4 stayed in bed, felt awful.). On 22-Mar-2021, HEADACHE (headaches) and ARTHRALGIA (super significant joint pain, very painful) had resolved. At the time of the report, FEELING ABNORMAL (felt awful), BACK PAIN (back pain), ILLNESS (very sick, day 4 stayed in bed, felt awful.), PAIN (all her body, in elbow both arm especially and back pain) and VACCINATION SITE PAIN (pain and tenderness at the injection site) outcome was unknown and FATIGUE (fatigue, tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site mass
Clinical narrative: a lump at the injection site; a lump at the injection site which has become red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (a lump at the injection site) and VACCINATION SITE ERYTHEMA (a lump at the injection site which has become red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION SITE MASS (a lump at the injection site) and VACCINATION SITE ERYTHEMA (a lump at the injection site which has become red). At the time of the report, VACCINATION SITE MASS (a lump at the injection site) and VACCINATION SITE ERYTHEMA (a lump at the injection site which has become red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LEVOTHYROXINE for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-054691 (Patient Link).
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure fluctuation, Blood pressure measurement
Clinical narrative: Lower blood pressure than his normal values which are high; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (Lower blood pressure than his normal values which are high) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     Concurrent medical conditions included Hypertensive. Concomitant products included GABAPENTIN and METFORMIN for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced BLOOD PRESSURE FLUCTUATION (Lower blood pressure than his normal values which are high). At the time of the report, BLOOD PRESSURE FLUCTUATION (Lower blood pressure than his normal values which are high) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Blood pressure measurement: low (Low) Lower than normal values.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had not been taking his high blood pressure medication for the last 7 days (Losartan, Lisinopril and 1 more).  Treatment information was not provided.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 03K20A?) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown.            No Concomitant medications was reported Treatment information was not provided
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: arm pain is the same arm that the patient receive the vaccine injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm pain is the same arm that the patient receive the vaccine injection) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (arm pain is the same arm that the patient receive the vaccine injection). At the time of the report, VACCINATION SITE PAIN (arm pain is the same arm that the patient receive the vaccine injection) outcome was unknown.            Concomitant product use was not provided by the reporter. No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included Osteoporosis (Infusion for osteoporosis (1 per year)). Concomitant products included VITAMIN D NOS and CALCIUM for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced VERTIGO (Vertigo). The patient was treated with Physical therapy for Vertigo. At the time of the report, VERTIGO (Vertigo) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Nausea
Clinical narrative: sweats; sore throat; headache; nausea; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003BB21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sweats; sore throat; headache; nausea; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea) and CHILLS (chills) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003BB21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, HYPERHIDROSIS (sweats), OROPHARYNGEAL PAIN (sore throat), HEADACHE (headache), NAUSEA (nausea), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: Fever; chills; Her arm is also tender and sore; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (chills) and VACCINATION SITE PAIN (Her arm is also tender and sore) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR), ACETYLSALICYLIC ACID (ECOTRIN), VITAMIN C [ASCORBIC ACID] and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PYREXIA (Fever), CHILLS (chills) and VACCINATION SITE PAIN (Her arm is also tender and sore). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (chills) and VACCINATION SITE PAIN (Her arm is also tender and sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: covid arm; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE REACTION (covid arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (covid arm). At the time of the report, VACCINATION SITE REACTION (covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications was reported Treatment information was not provided
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Insomnia, Muscle swelling, Pain in extremity
Clinical narrative: Sore arm; The muscle is swollen; It's kind of heated up; Tired; Arm pain / Really bad; Kept her up at night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain / Really bad), INSOMNIA (Kept her up at night), PAIN IN EXTREMITY (Sore arm), MUSCLE SWELLING (The muscle is swollen) and FEELING HOT (It's kind of heated up) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included METOPROLOL, ATORVASTATIN and RIVAROXABAN (XARELTO) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain / Really bad), INSOMNIA (Kept her up at night) and FATIGUE (Tired). On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MUSCLE SWELLING (The muscle is swollen) and FEELING HOT (It's kind of heated up). The patient was treated with DICLOFENAC (VOLTAREN [DICLOFENAC]) at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. On 12-Mar-2021, PAIN IN EXTREMITY (Arm pain / Really bad) and INSOMNIA (Kept her up at night) had resolved. At the time of the report, PAIN IN EXTREMITY (Sore arm), MUSCLE SWELLING (The muscle is swollen), FEELING HOT (It's kind of heated up) and FATIGUE (Tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications also include OTC allergy medication.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Event Outcome: From unknown to recovered updated.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Illness, Pyrexia, SARS-CoV-2 antibody test
Clinical narrative: very very very sick with it/ sicker than when I was with COVID; fever for 3 days, close to 102; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (very very very sick with it/ sicker than when I was with COVID) and PYREXIA (fever for 3 days, close to 102) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 27-Feb-2021. Concomitant products included TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (very very very sick with it/ sicker than when I was with COVID) and PYREXIA (fever for 3 days, close to 102). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ILLNESS (very very very sick with it/ sicker than when I was with COVID) and PYREXIA (fever for 3 days, close to 102) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, SARS-CoV-2 antibody test: positive (Positive) Positive. On an unknown date, Body temperature: 102 (High) had fever for 3 days.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication taken by the patient included hormone cream.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash pruritic, Vaccination site erythema, Vaccination site mass, Vaccination site reaction
Clinical narrative: Ring-like appearance around the area; Large that looked like fat deposits under the armpit of the same arm under the vaccination area; Floaters on the eye; Extremely fatigue; Red, swollen, and itchy rash; Red, swollen, and itchy rash; Red, swollen, and itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (Floaters on the eye), RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area) and VACCINATION SITE SWELLING (Red, swollen, and itchy rash) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TOPIRAMATE (TOPAMAX) and ATORVASTATIN for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE SWELLING (Red, swollen, and itchy rash) and VACCINATION SITE ERYTHEMA (Red, swollen, and itchy rash). On an unknown date, the patient experienced VITREOUS FLOATERS (Floaters on the eye), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area) and FATIGUE (Extremely fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form as required. On 22-Mar-2021, FATIGUE (Extremely fatigue) was resolving. At the time of the report, VITREOUS FLOATERS (Floaters on the eye), RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area), VACCINATION SITE SWELLING (Red, swollen, and itchy rash) and VACCINATION SITE ERYTHEMA (Red, swollen, and itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included an intra uterine device for birth control NOS. Treatment medication also included some anti-inflammatory medication like NSAIDs which were NOS.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vitreous floaters
Clinical narrative: Ring-like appearance around the area; Large that looked like fat deposits under the armpit of the same arm under the vaccination area; Floaters on the eye; Extremely fatigue; Red, swollen, and itchy rash; Red, swollen, and itchy rash; Red, swollen, and itchy rash; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (Floaters on the eye), RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area) and VACCINATION SITE SWELLING (Red, swollen, and itchy rash) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included TOPIRAMATE (TOPAMAX) and ATORVASTATIN for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE SWELLING (Red, swollen, and itchy rash) and VACCINATION SITE ERYTHEMA (Red, swollen, and itchy rash). On an unknown date, the patient experienced VITREOUS FLOATERS (Floaters on the eye), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area) and FATIGUE (Extremely fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form as required. On 22-Mar-2021, FATIGUE (Extremely fatigue) was resolving. At the time of the report, VITREOUS FLOATERS (Floaters on the eye), RASH PRURITIC (Red, swollen, and itchy rash), VACCINATION SITE REACTION (Ring-like appearance around the area), VACCINATION SITE MASS (Large that looked like fat deposits under the armpit of the same arm under the vaccination area), VACCINATION SITE SWELLING (Red, swollen, and itchy rash) and VACCINATION SITE ERYTHEMA (Red, swollen, and itchy rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication also included an intra uterine device for birth control NOS. Treatment medication also included some anti-inflammatory medication like NSAIDs which were NOS.
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test
Clinical narrative: Tested positive on Covid, the disease; This spontaneous case was reported by a consumer and describes the occurrence of ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease). At the time of the report, ASYMPTOMATIC COVID-19 (Tested positive on Covid, the disease) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was reported Treatment information was not provided
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: lots of sleep; dizziness; short of breath; feeling lots of malaise; fever; headache; lots of chills; lots of tirednessand fatigue; This spontaneous case was reported by a patient and describes the occurrence of HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise) and PYREXIA (fever) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise), PYREXIA (fever), HEADACHE (headache), CHILLS (lots of chills) and FATIGUE (lots of tirednessand fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise), PYREXIA (fever), HEADACHE (headache), CHILLS (lots of chills) and FATIGUE (lots of tirednessand fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Concomitant medications included inhaler for asthma
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Malaise, Pyrexia
Clinical narrative: lots of sleep; dizziness; short of breath; feeling lots of malaise; fever; headache; lots of chills; lots of tirednessand fatigue; This spontaneous case was reported by a patient and describes the occurrence of HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise) and PYREXIA (fever) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise), PYREXIA (fever), HEADACHE (headache), CHILLS (lots of chills) and FATIGUE (lots of tirednessand fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL 12 HOUR) at an unspecified dose and frequency. At the time of the report, HYPERSOMNIA (lots of sleep), DIZZINESS (dizziness), DYSPNOEA (short of breath), MALAISE (feeling lots of malaise), PYREXIA (fever), HEADACHE (headache), CHILLS (lots of chills) and FATIGUE (lots of tirednessand fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    Concomitant medications included inhaler for asthma
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Root canal infection, Swelling face
Clinical narrative: root canal; facial swelling; This spontaneous case was reported by a consumer and describes the occurrence of ROOT CANAL INFECTION (root canal) and SWELLING FACE (facial swelling) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced ROOT CANAL INFECTION (root canal) and SWELLING FACE (facial swelling). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, ROOT CANAL INFECTION (root canal) and SWELLING FACE (facial swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. The patient was treated with antibiotics(ongoing).
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified thyroid medication and blood pressure medication. Treatment Medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Spinal pain
Clinical narrative: Spinal pain; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (Spinal pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SPINAL PAIN (Spinal pain). At the time of the report, SPINAL PAIN (Spinal pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment information was not provided.   Reporter did not allow further contact
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Granulocyte count, Headache
Clinical narrative: her hands and feet were so cold; 101 temperature; Tired; Little Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (her hands and feet were so cold), PYREXIA (101 temperature), FATIGUE (Tired), HEADACHE (Little Headache) and CHILLS (Chills) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PERIPHERAL COLDNESS (her hands and feet were so cold), PYREXIA (101 temperature), FATIGUE (Tired), HEADACHE (Little Headache) and CHILLS (Chills). At the time of the report, PERIPHERAL COLDNESS (her hands and feet were so cold), PYREXIA (101 temperature), FATIGUE (Tired), HEADACHE (Little Headache) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 101 (Inconclusive) 101 temperature. On 10-Mar-2021, Granulocyte count: high (High) high. On 10-Mar-2021, Monocyte count: high (High) high.         No Concomitant medications was reported Treatment information was not provided